BioHarvest Sciences Inc. (BHST) Stock
Consumer Defensive · Packaged Foods · Member of Other US Stocks
BioHarvest Sciences Inc. (BHST) closed at USD 1.70 on 2026-10-15, a change of -82.7 % over the past year, with a market capitalization of USD 41.94M.
BioHarvest Sciences Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-15 | 1.70 |
| 2026-10-14 | 1.75 |
| 2026-10-13 | 1.82 |
| 2026-10-12 | 1.62 |
| 2026-10-09 | 1.66 |
| 2026-10-08 | 1.50 |
| 2026-10-07 | 1.49 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
BioHarvest Sciences Inc. key figures
- Previous close
- USD 1.70 (2026-10-15)
- 1-year change
- -82.7 %
- Market cap
- USD 41.94M
- Enterprise value
- USD 41.41M
- P/E ratio (trailing)
- -3.63
- P/E ratio (forward)
- -5.52
- EPS (trailing)
- -0.51
- EPS (forward)
- -0.34
- PEG ratio
- n/a
- Price to book
- 2.12
- Revenue growth
- 3.8 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 2.86
- Employees
- 89
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for BioHarvest Sciences Inc. and compare it with other stocks.
Analyze BHSTAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell BioHarvest Sciences Inc. shares.